Obinutuzumab: A FDA approved monoclonal antibody in the treatment of untreated chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is an adult lymphoid malignancy with a variable clinical course. There is considerable interest in the identification of new treatments, as most current approaches are not curative. While most patients respond to initial chemotherapy, relapsed disease is often resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachdeva, Mamta, Dhingra, Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318103/
https://www.ncbi.nlm.nih.gov/pubmed/25664270
http://dx.doi.org/10.4103/2229-516X.149245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318103/
https://www.ncbi.nlm.nih.gov/pubmed/25664270
http://dx.doi.org/10.4103/2229-516X.149245

Ejemplares similares